Postoperative radioactive iodine ablation and treatment of differentiated thyroid cancer Book Section

  


Author: Sabra, M. M.
Editor: Randolph, G. W.
Article/Chapter Title: Postoperative radioactive iodine ablation and treatment of differentiated thyroid cancer
Abstract: The use of radioactive iodine (RAI) therapy in the postoperative management of patients with differentiated thyroid cancer (DTC) is a highly controversial topic. The controversy lies in the proper selection of patients that are most likely to benefit from the therapy both in the short and long term. In this chapter, we explore in detail current positions regarding RAI therapy use in the postoperative setting and review the use of risk assessment models in properly selecting the patients most likely to benefit from therapy. © 2021 Elsevier Inc. All rights reserved.
Keywords: differentiated thyroid cancer; radioactive iodine ablation; postoperative management of thyroid cancer; radioactive iodine adjuvant therapy; selective use of radioactive iodine
Book Title: Surgery of the Thyroid and Parathyroid Glands. 3rd ed
ISBN: 978-0-323-66127-0
Publisher: Elsevier Inc.  
Publication Place: Philadelphia, PA
Date Published: 2021-01-01
Start Page: 447
End Page: 451
Language: English
DOI: 10.1016/b978-0-323-66127-0.00048-x
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136762893&doi=10.1016%2fB978-0-323-66127-0.00048-X&partnerID=40&md5=3b3007b24b1cb492cdb9833d6e55c419
Notes: Book Chapter: 48 -- Located within "Section 7: Postoperative Management" -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Mona M Sabra
    42 Sabra
Related MSK Work